Fny Investment Advisers, LLC Moderna, Inc. Transaction History

Fny Investment Advisers, LLC

$208 Million
Q3 2024

A detailed history of Fny Investment Advisers, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 15 shares of MRNA stock, worth $552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$552

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$63.64 - $125.14 $954 - $1,877	15 New	15 $1,000
Q4 2023 Jan 12, 2024	BUY	$69.51 - $104.43 $1,042 - $1,566	15 New	15 $1,000
Q2 2023 Jul 11, 2023	SELL	$118.5 - $160.53 $1,303 - $1,765	-11 Reduced 2.17%	497 $60,000
Q1 2023 Apr 12, 2023	BUY	$135.66 - $197.02 $68,915 - $100,086	508 New	508 $78,000
Q4 2021 Jan 10, 2022	SELL	$225.82 - $368.51 $32,292 - $52,696	-143 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$221.9 - $484.47 $6,878 - $15,018	31 Added 27.68%	143 $55,000
Q2 2021 Jul 14, 2021	SELL	$129.91 - $234.98 $76,906 - $139,108	-592 Reduced 84.09%	112 $26,000
Q1 2021 Apr 12, 2021	BUY	$109.18 - $185.98 $24,347 - $41,473	223 Added 46.36%	704 $92,000
Q4 2020 Jan 19, 2021	BUY	$65.74 - $169.86 $31,620 - $81,702	481 New	481 $50,000
Q2 2020 Jul 10, 2020	SELL	$29.67 - $80.0 $554,087 - $1.49 Million	-18,675 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$17.78 - $31.58 $332,041 - $589,756	18,675 New	18,675 $559,000
Q3 2019 Oct 25, 2019	SELL	$12.26 - $18.07 $263,590 - $388,505	-21,500 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$13.7 - $28.34 $294,550 - $609,310	21,500 New	21,500 $314,000
Q1 2019 Apr 17, 2019	SELL	$14.45 - $23.7 $21,675 - $35,550	-1,500 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$13.52 - $18.8 $20,280 - $28,200	1,500 New	1,500 $22,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Account

Fny Investment Advisers, LLC Moderna, Inc. Transaction History